Monday, May 22, 2017

Oxyrane Raises USD49.5 Million In Series D Financing

(1888 PressRelease) Global Private Group has invested in Biopharmaceutical Company dedicated to the development of enzyme replacement therapies (ERT) to treat lysosomal storage diseases, a class of more than forty rare inherited diseases.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)